Beta Bionics, Inc. Common Stock (BBNX) — Strategic Asset Allocation Index
Beta Bionics, Inc. Common Stock (BBNX) has a Strategic Asset Allocation Index of 14.7% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $39.87 Million) total $39.87 Million, measured against net assets of $271.25 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Beta Bionics, Inc. Common Stock liquidity resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Beta Bionics, Inc. Common Stock Strategic Asset Allocation Index (2024–2025)
This chart shows how Beta Bionics, Inc. Common Stock's Strategic Asset Allocation Index has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the index stands at 14.7%, representing strategic assets of $39.87 Million against net assets of $271.25 Million USD. See BBNX FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Beta Bionics, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Beta Bionics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Beta Bionics, Inc. Common Stock worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 15.8% | $45.43 Million | $- | $45.43 Million | $287.61 Million | ▲ +15.8 pp |
| 2024 | 0.0% | $0.00 | $- | $0.00 | $76.01 Million | — |